James is a National Heart Foundation Future Leader Fellow and Team Leader of Muscle Signalling at the Murdoch Children's Research Institute. His research focuses on uncovering the molecular mechanisms of genetic cardiomyopathies and developing precision therapies to treat these debilitating conditions.

Dr Kizana is a clinician/researcher at the Westmead Research Hub who divides his time between clinical cardiac electrophysiology and translational research. Dr Kizana is Co-Director of the Centre for Heart Research and Cardiac Gene Therapy Group Leader at the Westmead Institute for Medical Research, The University of Sydney. To dovetail his clinical and research activities, he leads a research group focused on the development novel therapies for cardiac disease. The group are developing AAV vectors as a platform technology for targeting human myocardium and using these in preclinical models of human disease to advance gene therapy for heart disease.

Dr Kizana is a clinician/researcher at the Westmead Research Hub who divides his time between clinical cardiac electrophysiology and translational research. Dr Kizana is Co-Director of the Centre for Heart Research and Cardiac Gene Therapy Group Leader at the Westmead Institute for Medical Research, The University of Sydney. To dovetail his clinical and research activities, he leads a research group focused on the development novel therapies for cardiac disease. The group are developing AAV vectors as a platform technology for targeting human myocardium and using these in preclinical models of human disease to advance gene therapy for heart disease.

James is a National Heart Foundation Future Leader Fellow and Team Leader of Muscle Signalling at the Murdoch Children's Research Institute. His research focuses on uncovering the molecular mechanisms of genetic cardiomyopathies and developing precision therapies to treat these debilitating conditions.